Hydroxychloroquine Dose Calculator - Weight Safety

A hydroxychloroquine dose calculator compares an entered hydroxychloroquine sulfate schedule with actual body weight and the commonly cited 5 mg/kg/day retinal-safety ceiling. The calculation supports medication review, chart checking, pharmacy discussion, and clinical education. It does not diagnose disease, choose therapy, replace prescribing judgment, or decide whether hydroxychloroquine should be started, stopped, or changed.

The calculation focuses on the long-term dose-risk question that often appears when hydroxychloroquine is used for rheumatologic or dermatologic disease. The tool converts pounds to kilograms when needed, averages intermittent weekly schedules, reports milligrams per kilogram per day, and shows the distance between the entered schedule and the weight-based ceiling. A renal-risk flag is included because kidney disease is part of retinal-toxicity risk assessment, although kidney function itself is not estimated here.

The output is meant to make a medication list easier to discuss. A chart may show a prescription as "take two tablets daily," while eye-screening guidance is often framed as milligrams per kilogram per day. Converting both statements into the same unit helps clinicians, pharmacists, and eye-care professionals see whether the current schedule needs closer review.

The calculator also separates active-day dose from average daily dose because hydroxychloroquine schedules sometimes alternate. For example, a schedule may use 400 mg on weekdays and no tablets on weekends, or 200 mg on some days and 400 mg on others. Averaging the weekly amount avoids treating every nonstandard schedule as if it were taken seven days per week.

The form does not ask for diagnosis, race, sex, pregnancy status, laboratory values, or eye-test results because those inputs would imply a more complete clinical model than the calculator provides. Keeping the input set narrow makes the output easier to verify: weight, schedule, tablet strength, and the resulting comparison with a published dose ceiling.

Hydroxychloroquine dosing can involve disease activity, duration of therapy, tablet availability, eye-screening history, kidney function, pregnancy context, drug interactions, adherence, and adverse effects. This calculator handles only the arithmetic needed to make a schedule transparent. A broader Dosage Calculator can support general medication strength and volume conversions when a non-hydroxychloroquine dose must be checked separately.

The formula starts with actual body weight. If weight is entered in pounds, the calculator divides by 2.2046226218 to convert it to kilograms. It then multiplies kilograms by 5 to estimate the daily ceiling used for retinal-safety review. The entered active-day dose is multiplied by dosing days per week, then divided by seven to create an average daily dose.

According to DailyMed Plaquenil labeling, adult rheumatic-disease dosing includes chronic dosage of 200 mg once daily to 400 mg daily, and daily doses exceeding 5 mg/kg actual weight increase retinopathy incidence. The calculator cites that label context while keeping treatment decisions outside the arithmetic.

The dose-per-kilogram calculation is intentionally based on hydroxychloroquine sulfate milligrams, matching common tablet labeling. Some references also discuss hydroxychloroquine base equivalents, but patients and medication lists usually display the sulfate tablet strength. Mixing sulfate and base values can create a misleading comparison, so the page keeps all entered and displayed dose values in sulfate milligrams.

A result can sit exactly at the ceiling, below it, or above it. At 80 kg, 400 mg daily equals 5 mg/kg/day. At 70 kg, the same 400 mg daily equals about 5.71 mg/kg/day. At 70 kg with 400 mg taken five days per week, the weekly average is about 285.7 mg/day, or roughly 4.08 mg/kg/day. Those examples show why weight and schedule both matter.

The weekly tablet ceiling is calculated by multiplying the daily weight-based ceiling by seven and dividing by tablet strength. Because tablets, prescriptions, and local instructions vary, this value is displayed as a schedule-review aid rather than a recommended number of tablets. Weight-based medication comparisons can also be sensitive to the body-weight assumption; the Adjusted Weight Calculator explains why some medication contexts review actual, ideal, or adjusted body weight differently.

Hydroxychloroquine dose review is not just a tablet-count problem. A 400 mg daily schedule may be below the 5 mg/kg/day ceiling for a heavier adult and above it for a smaller adult. The same weekly tablet count can also produce a different average daily dose when tablets are taken five, six, or seven days per week.

As published in the 2025 American Academy of Ophthalmology revision abstract, the recommended daily dosage remains at no more than 5.0 mg/day/kg real weight. The page applies that ceiling as a screening calculation, not as a disease-specific dose target.

The result is best read as a medication-safety prompt. A value above 5 mg/kg/day means the entered schedule is above the cited retinal-safety ceiling and deserves prescriber review. A value below the ceiling does not prove that therapy is without risk. For other medication dose examples, the Gabapentin Dosage Calculator shows a separate renal-dose workflow with a different clinical basis.

The calculator does not decide whether a lower schedule would control disease. That distinction is clinically important because undertreatment can also cause harm. The arithmetic can identify a dose that exceeds a screening threshold, but it cannot weigh disease flare risk, organ involvement, prior medication response, pregnancy planning, retinal results, or the reason the schedule was chosen.

The renal-risk selector should also be interpreted narrowly. It is a visible reminder that kidney disease changes risk assessment, not a kidney-dose adjustment engine. If reduced renal function is present, the entered schedule may need additional review even when the calculated dose per kilogram appears below the ceiling.

The most reliable workflow starts with the current prescription instructions, not memory. Hydroxychloroquine schedules may be written as one tablet daily, two tablets daily, alternating doses, or a custom weekly pattern. The calculator accepts the amount taken on active dosing days and the number of active dosing days per week so a schedule can be compared as a weekly average.

Medication records should distinguish prescribed schedule from actual adherence. The calculator is usually most appropriate for checking the intended schedule written by a clinician. If missed doses, extra doses, or temporary holds are being reviewed, that situation may require a different clinical conversation because average exposure over time may not match the prescription label.

If a prescription contains more than one instruction, the active-day dose should reflect the total amount taken on the days being averaged. For an alternating schedule, the easiest method is often to calculate total tablets for the week first, then confirm that the active-day and days-per-week fields reproduce the same weekly total.

The result can be saved in a chart note as a compact line: actual weight, entered schedule, average daily dose, dose per kilogram, and margin from the 5 mg/kg/day ceiling. That format is easier to audit than a statement that the dose was "checked" without showing the arithmetic. The same format also helps when weight changes make a previously acceptable schedule worth revisiting.

Medication review often involves both dose math and kidney context. When renal function is part of the discussion, the GFR Calculator provides a separate kidney-function estimate for clinical documentation, while hydroxychloroquine prescribing remains clinician-directed.

This calculator is appropriate when a hydroxychloroquine schedule needs a transparent weight-based check. It can support medication reconciliation, rheumatology chart review, ophthalmology screening notes, pharmacy counseling documentation, and student learning. It is especially relevant when the schedule is not simply 200 mg daily or 400 mg daily, because weekly averaging makes alternating patterns easier to evaluate.

The calculation is also relevant when a patient's weight has changed. A fixed 400 mg daily schedule has a lower milligram-per-kilogram value at a higher weight and a higher value at a lower weight. Weight loss, frailty, or a transition from pediatric to adult care can therefore change the interpretation of the same tablet count.

• •
  Schedule clarity: A weekly tablet pattern is translated into average milligrams per day and milligrams per kilogram per day.
• •
  Risk triage: The output identifies schedules above the cited 5 mg/kg/day ceiling for follow-up review.
• •
  Chart documentation: Weight, dose, weekly average, and ceiling margin can be recorded together.
• •
  Teaching support: The calculation shows why body weight and weekly schedule both matter.

The calculator should be treated as a dose-screening worksheet, not a treatment instruction. A schedule below the ceiling can still require monitoring, and a schedule above the ceiling may still reflect a clinician's short-term plan or a situation needing specialist review. For other over-the-counter medication-limit comparisons, the Aleve Dosage Calculator illustrates how label limits differ by drug and population.

The page may be less useful for acute malaria regimens, unusual compounding situations, pediatric patients below tablet-label constraints, or patients whose instructions are based on drug-level monitoring. Those cases often require indication-specific references and direct clinician interpretation. The safest reading is that this calculator clarifies one dosing threshold, while the care team decides what the threshold means for the individual case.

Hydroxychloroquine dose interpretation depends on more than the arithmetic output. According to the American College of Rheumatology hydroxychloroquine patient fact sheet, adult rheumatic-disease dosing is typically 200 mg to 400 mg per day, often described as 5 mg/kg with a maximum of 400 mg daily. That patient-facing summary aligns with weight-based review while emphasizing professional care.

The current dose is only one part of retinal-toxicity risk. Duration of therapy matters because risk accumulates with years of exposure. Baseline retinal status matters because screening must distinguish medication toxicity from unrelated eye disease. Concomitant medicines, especially tamoxifen, can alter risk interpretation. Renal disease may increase concern because reduced clearance can raise exposure.

Tablet rounding is often the practical constraint behind weekly schedules. A calculated ceiling of 325 mg/day cannot be matched exactly with whole 200 mg tablets every day. A clinician might therefore consider an alternating weekly pattern, a lower daily schedule, or another plan based on disease control and monitoring. The calculator reports the arithmetic without selecting among those options.

The calculator deliberately avoids disease-specific recommendations because lupus, rheumatoid arthritis, dermatologic disease, and malaria-related contexts do not share one simple treatment pathway. For body-size context outside medication limits, the Ideal Weight Calculator provides a non-prescribing comparison of adult height-based weight formulas.